Masashi Ukai

961 total citations
30 papers, 792 citations indexed

About

Masashi Ukai is a scholar working on Urology, Molecular Biology and Physiology. According to data from OpenAlex, Masashi Ukai has authored 30 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Urology, 8 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Masashi Ukai's work include Urinary Bladder and Prostate Research (19 papers), Nitric Oxide and Endothelin Effects (7 papers) and Pelvic floor disorders treatments (6 papers). Masashi Ukai is often cited by papers focused on Urinary Bladder and Prostate Research (19 papers), Nitric Oxide and Endothelin Effects (7 papers) and Pelvic floor disorders treatments (6 papers). Masashi Ukai collaborates with scholars based in Japan, Netherlands and United Kingdom. Masashi Ukai's co-authors include Masao Sasamata, Keiji Miyata, Akiyoshi Ohtake, Shuichi Sato, Toshiyuki Takasu, Tetsuo Matsui, Tatsuya Maruyama, Osamu Yamaguchi, Itsuro Nagase and Hisashi Uchida and has published in prestigious journals such as FEBS Letters, The Journal of Urology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Masashi Ukai

28 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masashi Ukai Japan 14 521 277 230 129 122 30 792
Kazuyasu Maruyama Japan 12 87 0.2× 45 0.2× 218 0.9× 230 1.8× 115 0.9× 27 532
Hanumanthappa Nandeesha India 14 160 0.3× 39 0.1× 59 0.3× 126 1.0× 213 1.7× 31 589
Arianna Bettiga Italy 16 80 0.2× 26 0.1× 33 0.1× 240 1.9× 72 0.6× 38 624
Mi-Hye Kwon South Korea 13 66 0.1× 19 0.1× 55 0.2× 236 1.8× 116 1.0× 22 556
Giovanni Crea Italy 4 54 0.1× 19 0.1× 47 0.2× 289 2.2× 42 0.3× 6 509
Jee-Young Han South Korea 10 25 0.0× 14 0.1× 23 0.1× 91 0.7× 167 1.4× 16 394
Dariusz Suchy Poland 10 13 0.0× 15 0.1× 57 0.2× 270 2.1× 139 1.1× 12 622
Sylvie Delaflotte France 14 22 0.0× 17 0.1× 24 0.1× 188 1.5× 39 0.3× 29 549
Ruping Pan China 14 13 0.0× 12 0.0× 198 0.9× 261 2.0× 125 1.0× 19 818

Countries citing papers authored by Masashi Ukai

Since Specialization
Citations

This map shows the geographic impact of Masashi Ukai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Ukai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Ukai more than expected).

Fields of papers citing papers by Masashi Ukai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Ukai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Ukai. The network helps show where Masashi Ukai may publish in the future.

Co-authorship network of co-authors of Masashi Ukai

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Ukai. A scholar is included among the top collaborators of Masashi Ukai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Ukai. Masashi Ukai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Korstanje, Cees, et al.. (2017). Translational science approach for assessment of cardiovascular effects and proarrhythmogenic potential of the beta-3 adrenergic agonist mirabegron. Journal of Pharmacological and Toxicological Methods. 87. 74–81. 13 indexed citations
3.
Korstanje, Cees, et al.. (2013). Additive effects for increased bladder storage function with the antimuscarinic drug solifenacin and the selective ß3-adrenergic agonist mirabegron in two rat models for in vivo bladder function.. Neurourology and Urodynamics. 2 indexed citations
4.
Shimizu, Takahiro, Takuto Fujii, Yûji Takahashi, et al.. (2013). Up-regulation of Kv7.1 channels in thromboxane A2-induced colonic cancer cell proliferation. Pflügers Archiv - European Journal of Physiology. 466(3). 541–548. 16 indexed citations
5.
Ukai, Masashi, Akiyoshi Someya, Akiyoshi Ohtake, et al.. (2013). Pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in cynomolgus monkeys. Naunyn-Schmiedeberg s Archives of Pharmacology. 386(11). 1001–1008. 13 indexed citations
6.
Ukai, Masashi, Akiyoshi Someya, Akiyoshi Ohtake, et al.. (2012). In vitro and in vivo pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 386(3). 247–253. 37 indexed citations
7.
8.
Suzuki, Masanori, Masashi Ukai, Masao Sasamata, & Nobuo Seki. (2012). Pharmacological and clinical profile of mirabegron (Betanis<sup>&reg;</sup>): a new therapeutic agent for overactive bladder. Folia Pharmacologica Japonica. 139(5). 219–225. 1 indexed citations
9.
Ukai, Masashi, Miho Watanabe, Akiyoshi Ohtake, et al.. (2010). 266 MIRABEGRON (YM178), A NOVEL ß3-ADRENOCEPTOR (AR) AGONIST, INCREASED FUNCTIONAL BLADDER CAPACITY AND DECREASED MICTURITION FREQUENCY IN CONSCIOUS WATER-LOADED CYNOMOLGUS MONKEYS. European Urology Supplements. 9(2). 111–111. 1 indexed citations
10.
Takasu, Toshiyuki, Masashi Ukai, Shuichi Sato, et al.. (2007). Effect of (R)-2-(2-Aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} Acetanilide (YM178), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function. Journal of Pharmacology and Experimental Therapeutics. 321(2). 642–647. 261 indexed citations
11.
Ukai, Masashi, Hironori Yuyama, Akira Fujimori, et al.. (2007). In vitro and in vivo effects of endothelin-1 and YM598, a selective endothelin ETA receptor antagonist, on the lower urinary tract. European Journal of Pharmacology. 580(3). 394–400. 10 indexed citations
12.
Maruyama, Shuji, Tomomi Oki, Yukiko Noguchi, et al.. (2007). Urodynamics and bladder muscarinic receptors in rats with cerebral infarction and bladder outlet obstruction. Neuroscience Letters. 414(1). 80–84. 12 indexed citations
13.
Ohtake, Akiyoshi, Hironori Yuyama, Masashi Ukai, et al.. (2006). Effects of alpha(1)-adrenoreceptor antagonists on pupil diameter and intraurethral pressure in rabbits. Pure Amsterdam UMC. 34. 653–661. 3 indexed citations
14.
Someya, Akiyoshi, Hironori Yuyama, Akira Fujimori, et al.. (2006). Effect of YM598, a selective endothelin ETA receptor antagonist, on endothelin-1-induced bone formation. European Journal of Pharmacology. 543(1-3). 14–20. 9 indexed citations
15.
Michel, Martin C., Hiroko Okutsu, Yukiko Noguchi, et al.. (2006). In vivo studies on the effects of α1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits. Naunyn-Schmiedeberg s Archives of Pharmacology. 372(5). 346–353. 29 indexed citations
16.
Ohtake, Akiyoshi, Masashi Ukai, Yukiko Noguchi, et al.. (2006). Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: Comparison with effect on intraurethral pressure. European Journal of Pharmacology. 545(2-3). 185–191. 27 indexed citations
17.
Ukai, Masashi, Hironori Yuyama, Yukiko Noguchi, et al.. (2006). Participation of endogenous endothelin and ETA receptor in premicturition contractions in rats with bladder outlet obstruction. Naunyn-Schmiedeberg s Archives of Pharmacology. 373(3). 197–203. 9 indexed citations
18.
Ohtake, Akiyoshi, Masashi Ukai, Seiji Kobayashi, et al.. (2004). In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats. European Journal of Pharmacology. 492(2-3). 243–250. 104 indexed citations
19.
Yuyama, Hironori, Yukiko Noguchi, Akira Fujimori, et al.. (2004). Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist. European Journal of Pharmacology. 498(1-3). 171–177. 11 indexed citations
20.
Yuyama, Hironori, Yukiko Noguchi, Akira Fujimori, et al.. (2004). Pharmacological Characterization of YM598, a Selective Endothelin-A Receptor Antagonist. Journal of Cardiovascular Pharmacology. 44(Supplement 1). S390–S393. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuyasu Maruyama Breakdown of academic impact, for papers by Hanumanthappa Nandeesha Breakdown of academic impact, for papers by Arianna Bettiga Breakdown of academic impact, for papers by Mi-Hye Kwon Breakdown of academic impact, for papers by Giovanni Crea Breakdown of academic impact, for papers by Jee-Young Han Breakdown of academic impact, for papers by Dariusz Suchy Breakdown of academic impact, for papers by Sylvie Delaflotte Breakdown of academic impact, for papers by Ruping Pan
Rankless by CCL
2026